1. Home
  2. QTRX vs SCM Comparison

QTRX vs SCM Comparison

Compare QTRX & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.53

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

HOLD

Current Price

$8.10

Market Cap

267.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
SCM
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Finance/Investors Services
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
267.2M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
QTRX
SCM
Price
$3.53
$8.10
Analyst Decision
Hold
Hold
Analyst Count
2
1
Target Price
$6.00
$9.00
AVG Volume (30 Days)
1.1M
190.7K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
14.22%
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$37,632,000.00
N/A
Revenue This Year
$25.49
$0.33
Revenue Next Year
$10.04
N/A
P/E Ratio
N/A
$138.33
Revenue Growth
64.52
N/A
52 Week Low
$2.40
$8.16
52 Week High
$8.77
$15.39

Technical Indicators

Market Signals
Indicator
QTRX
SCM
Relative Strength Index (RSI) 57.52 32.58
Support Level $3.11 N/A
Resistance Level $3.81 $9.27
Average True Range (ATR) 0.35 0.29
MACD 0.04 -0.05
Stochastic Oscillator 56.25 13.57

Price Performance

Historical Comparison
QTRX
SCM

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.

Share on Social Networks: